Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel

00:07 EDT 17 May 2017 | PR Newswire
This article has expired, however you can still download the PDF.
SAN DIEGO, May 17, 2017 /PRNewswire/ -- ResMed today issued the following statement from David Pendarvis, the company's global general counsel and chief administrative officer: Experience the interactive Multimedia News Release here: https://www....

Other Sources for this Article


More From BioPortfolio on "Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel"

Quick Search

Relevant Topics

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...

Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...